Correction to: Translational Psychiatry 10.1038/s41398-022-02164-w, published online 24 September 2022
The original version of this article unfortunately contained some mistakes. The authors noticed formatting issues and errors in the tables. These are as follows:
Table 1: Standard deviation for IL10 (NCPTSD column) should read “.26”, not “26”
Table 2: NC-PTSD header misaligned
Table 3: Formatting is misaligned (e.g., there are no results in the right columns)
Covariates is spelled wrong
Table 3 note refers to entering neuropsychological variables into second step, but it was GrimAge Residuals that were entered into second step
Table 4: GFAP and NFL results are not in the correct row
Table 1.
Participant characteristics and descriptive statistics.
| NCPTSD (N = 647) | TRACTS (N = 434) | |||
|---|---|---|---|---|
| Variable | M (SD) | n (%) | M (SD) | n (%) |
| Demographics | ||||
| Sex (male) | 407 (62.9) | 392 (90.3) | ||
| Age | 51.85 (10.60) | 32.44 (8.63) | ||
| Race | ||||
| White | 525 (81.1) | 322 (74.2) | ||
| Black/African American | 80 (12.4) | 37 (8.5) | ||
| Asian | 8 (1.2) | 6 (1.4) | ||
| American Indian/Alaska Native | 57 (8.8) | 3 (0.7) | ||
| Hawaiian/Other Pacific Islander | 2 (0.3) | 2 (0.5) | ||
| Unknown | 38 (5.9) | 2 (0.5) | ||
| Psychiatric | ||||
| Lifetime PTSD severity/Dx | 60.12 (32.93) | 389 (60.1) | 69.00 (32.98) | 351 (76.8) |
| # of Trauma types | 9.90 (4.26) | 1.95 (1.80) | ||
| Lifetime AUD severity/Dx | 8.03 (7.81) | 376 (58.8) | 286 (65.9) | |
| Lifetime Non-AUD SUD severity/Dx | 5.24 (9.53) | 191 (29.7) | 137 (31.6) | |
| Lifetime ASPD severity/Dx | 5.19 (5.80) | 22 (4.8) | ||
| Neuropsychological | ||||
| AGNG | 11.56 (9.19) | |||
| Stroopb | 26.59 (12.14) | |||
| CVLT-IIc | 48.33 (9.88) | |||
| Biological | ||||
| CRP (log) | −0.77 (0.29) | |||
| GGT (log) | 1.39 (0.24) | |||
| WBC | 6.28 (1.71) | |||
| AB40 (log) | 2.32 (0.07) | |||
| AB42 (log) | 0.91 (0.08) | |||
| BDNF (log) | 3.41 (0.38) | 3.10 (0.47) | ||
| GFAP (log) | 1.79 (0.16) | |||
| NFL (log) | 0.72 (0.19) | |||
| NSE (log) | 4.32 (0.26) | 4.07 (0.21) | ||
| TAU4 (log) | 0.16 (0.23) | |||
| PNF (log) | 1.41 (0.35) | |||
| Eotaxin (log) | 1.61 (0.14) | |||
| IL10 (log) | −0.10 (26) | −0.16 (0.21) | ||
| IL6 (log) | 0.19 (0.31) | 0.14 (0.27) | ||
| TNF-α (log) | 0.53 (0.20) | 0.43 (0.13) | ||
NCPTSD National Center for PTSD cohort, TRACTS Translational Research Center for TBI and stress disorders cohort, M mean, SD standard deviation, PTSD posttraumatic stress disorder, dx diagnosis, CRP C-reactive protein, GGT gamma-glutamyl transferase, WBC total measured white blood cell counts, AGNG affective go/no-go task, CVLT-II California verbal learning test second edition, AB40/AB42 amyloid ß 40/42, BDNF brain-derived neurotrophic factor, GFAP glial fibrillary acidic protein, NFL neurofilament light, NSE neuron-specific enolase, PNF phosphorylated neurofilament heavy, IL10/6 interleukin 6/10, TNF-α tumor necrosis factor.
aRaw scores for total commission error = Total positive commissions + total negative commissions.
bScaled scores adjusted for performance = Inhibition – (Color naming + Word reading)/2.
cTotal words recalled across five learning trials.
Table 2.
Psychopathology as a predictor of GrimAge residuals in both cohorts.
| NCPTSD | ||||
|---|---|---|---|---|
| Variable | β | B | SE | p |
| Covariates: | ||||
| PC1 | 0.075 | 9.148 | 4.616 | 0.048 |
| PC2 | −0.023 | −2.722 | 4.443 | 0.540 |
| PC3 | −0.003 | −0.397 | 4.594 | 0.931 |
| CD8-T | 0.064 | 7.720 | 4.646 | 0.097 |
| CD4-T | −0.038 | −3.163 | 3.245 | 0.330 |
| NK | −0.241 | −23.402 | 3.566 | <0.001 |
| B-cell | −0.145 | −16.815 | 4.304 | <0.001 |
| Monocytes | −0.044 | −7.601 | 6.932 | 0.273 |
| Sex | 0.344 | 3.178 | 0.359 | <0.001 |
| Primary Predictors | ||||
| Externalizing Factor Score | 0.345 | 0.351 | 0.044 | <0.001 |
| Distress Factor Score | −0.120 | −0.178 | 0.095 | 0.062 |
| Fear Factor Score | 0.018 | 0.008 | 0.025 | 0.738 |
| Lifetime PTSD Severity | 0.056 | 0.008 | 0.006 | 0.215 |
| TRACTS | ||||
| Variable | β | B | SE | p |
| Covariates: | ||||
| PC1 | −0.186 | −15.297 | 3.984 | <0.001 |
| PC2 | 0.022 | 2.064 | 4.485 | <0.001 |
| PC3 | 0.053 | 4.814 | 4.288 | 0.262 |
| CD8-T | −0.233 | −20.689 | 4.174 | <0.001 |
| CD4-T | −0.144 | −9.883 | 3.346 | 0.003 |
| NK | −0.238 | −23.583 | 4.639 | <0.001 |
| B-cell | −0.051 | −7.153 | 7.010 | 0.308 |
| Monocytes | −0.108 | −14.293 | 6.473 | 0.028 |
| Sex | −0.150 | −1.691 | 0.527 | 0.001 |
| Primary Predictors: | ||||
| Lifetime AUD dx | 0.077 | 0.541 | 0.339 | 0.112 |
| Lifetime non-AUD SUD dx | 0.104 | 0.747 | 0.339 | 0.028 |
| Lifetime PTSD dx | 0.149 | 1.165 | 1.220 | 0.001 |
Results based on hierarchical regression models with covariates entered into the first step and psychopathology variables entered in the second. The △R2 coefficients were significant for the second step across models. PC Principal component, CD Cluster of differentiation, NK Natural killer, PTSD Posttraumatic stress disorder, AUD Alcohol use disorder, SUD Substance use disorder, dx Diagnosis, β Standardized beta, B Unstandardized beta SE Standard error for unstandardized beta.
Table 3.
GrimAge residuals as a predictor of neuropsychological constructs.
| AGNG | Stroop | CVLT-II | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Variable | β | p | padj | β | p | padj | β | p | padj |
| Covariates | |||||||||
| Sex | 0.011 | 0.835 | – | −0.003 | 0.955 | – | 0.033 | 0.518 | – |
| Age | 0.006 | 0.901 | – | −0.041 | 0.429 | – | −0.171 | 0.001 | – |
| Primary Predictor: | |||||||||
| GrimAge Residuals | 0.136 | 0.007 | 0.021 | 0.052 | 0.318 | .318 | −0.122 | 0.015 | 0.023 |
Results based on hierarchical regression models with covariates entered into the first step and GrimAge Residuals entered in the second. △R2 coefficients were significant for the second step across models with significant second step effects. AGNG Affective Go/No-Go Task, CVLT-II California Verbal Learning Test: Second edition, PTSD Posttraumatic stress disorder, AUD Alcohol use disorder, MDD Major depressive disorder, padj p-value adjusted for multiple testing by controlling the false discovery rate (FDR) of 5%.
Table 4.
Associations between GrimAge residuals and metabolic, immune, and neurology markers.
| TRACTS | NCPTSD | |||||
|---|---|---|---|---|---|---|
| Variable | β | p | padj | β | p | padj |
| Metabolic, Immune, and Oxidative Stress | ||||||
| MetS | 0.139 | <0.001 | <0.001 | – | – | – |
| WBC | 0.324 | <0.001 | <0.001 | – | – | – |
| GGT | 0.161 | 0.001 | 0.003 | – | – | – |
| Inflammatory Markers | ||||||
| CRP | 0.220 | <0.001 | <0.001 | – | – | – |
| Eotaxin | 0.108 | 0.026 | 0.059 | – | – | – |
| IL10 | 0.072 | 0.165 | 0.264 | 0.049 | 0.281 | 0.281 |
| IL6 | 0.286 | <0.001 | <0.001 | 0.341 | <0.001 | <0.001 |
| TNF-alpha | 0.077 | 0.135 | 0.240 | 0.156 | <0.001 | <0.001 |
| Neurologic Markers | ||||||
| GFAP | −0.132 | 0.008 | 0.021 | – | – | – |
| NFL | −0.055 | 0.266 | 0.387 | – | – | – |
| pNF | 0.001 | 0.985 | 0.985 | – | – | – |
| AB42 | 0.052 | 0.316 | 0.421 | – | – | – |
| AB40 | 0.080 | 0.122 | 0.240 | – | – | – |
| NSE | 0.043 | 0.391 | 0.447 | 0.072 | 0.107 | 0.143 |
| BDNF | 0.043 | 0.386 | 0.447 | 0.071 | 0.114 | 0.143 |
| Tau4 | 0.025 | 0.661 | 0.705 | – | – | – |
Results based on hierarchical regression models controlling for age and sex (covariate effects not shown for simplicity). The △R2 coefficients were significant for the second step across models with significant second step effects. MetS Metabolic Syndrome, WBC Total measured white blood cell count, GGT Gamma-Glutamyl Transferase, CRP C-reactive protein, IL10/IL6 Interleukin 10/6, TNF-alpha Tumor necrosis factor, GFAP Glial fibrillary acidic protein, NFL Neurofilament light, pNF Phosphorylated neurofilament heavy chain, AB42/AB40 Amaloyd beta 40/42, NSE Neuron specific enolase, BDNF Brain derived neurotrophic factor, padj p-value adjusted for multiple testing by controlling the false discovery rate (FDR) of.
The correct tables can be found below. The original article has been corrected.
Footnotes
The original article can be found online at 10.1038/s41398-022-02164-w.
